NPI: 1295319085 · LAS VEGAS, NV 89131 · Emergency Medicine Physician · NPI assigned 05/08/2021
Authorized official FILTON, STEVE controls 20+ related entities in our dataset. Read more
| Authorized Official | FILTON, STEVE (EXEC VP - CFO) |
| Parent Organization | CENTENNIAL HILLS HOSPITAL MEDICAL CENTER |
| NPI Enumeration Date | 05/08/2021 |
Other providers sharing the same authorized official: FILTON, STEVE
| Year | Claims | Total Paid |
|---|---|---|
| 2022 | 13,199 | $300K |
| 2023 | 18,323 | $473K |
| 2024 | 12,355 | $353K |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 99284 | Emergency department visit for the evaluation and management, high severity | 3,211 | 2,934 | $275K |
| 99285 | Emergency department visit for the evaluation and management, high severity with immediate threat to life | 2,277 | 2,041 | $234K |
| 99283 | Emergency department visit for the evaluation and management, moderate severity | 3,139 | 2,938 | $185K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 398 | 366 | $74K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 2,039 | 1,710 | $64K |
| 87636 | Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B | 749 | 715 | $52K |
| 96375 | Therapeutic injection; each additional sequential IV push | 1,452 | 1,204 | $30K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 765 | 700 | $27K |
| 80053 | Comprehensive metabolic panel | 1,907 | 1,693 | $14K |
| 96361 | Intravenous infusion, hydration; each additional hour | 1,310 | 1,142 | $13K |
| 71046 | Radiologic examination, chest; 2 views | 861 | 828 | $12K |
| 70450 | Computed tomography, head or brain; without contrast material | 167 | 160 | $12K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 2,944 | 2,564 | $12K |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | 599 | 578 | $12K |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | 119 | 113 | $11K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 1,472 | 1,276 | $9K |
| 71045 | Radiologic examination, chest; single view | 1,171 | 1,078 | $9K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 508 | 465 | $8K |
| 84702 | 1,062 | 952 | $7K | |
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | 627 | 593 | $6K |
| 84484 | 1,379 | 865 | $6K | |
| 36415 | Collection of venous blood by venipuncture | 3,201 | 2,734 | $6K |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 689 | 607 | $6K |
| 83690 | 1,209 | 1,066 | $5K | |
| 80048 | Basic metabolic panel (calcium, ionized) | 1,072 | 976 | $4K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 78 | 69 | $4K |
| 81001 | 1,774 | 1,602 | $4K | |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | 116 | 110 | $4K |
| 87086 | Culture, bacterial; quantitative colony count, urine | 806 | 758 | $4K |
| C9803 | Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | 1,284 | 1,206 | $2K |
| 81025 | 654 | 614 | $2K | |
| J2270 | Injection, morphine sulfate, up to 10 mg | 644 | 575 | $2K |
| 83605 | 207 | 175 | $2K | |
| 85379 | 113 | 107 | $846.00 | |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 15 | 14 | $781.43 |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | 27 | 27 | $757.54 |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | 48 | 46 | $578.59 |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | 634 | 579 | $573.89 |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | 585 | 547 | $506.50 |
| 85610 | 202 | 174 | $492.32 | |
| 96376 | 51 | 40 | $489.09 | |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | 78 | 69 | $477.20 |
| 81003 | 295 | 272 | $459.69 | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | 1,283 | 1,093 | $411.63 |
| 83735 | 51 | 48 | $287.18 | |
| 73564 | 12 | 12 | $241.61 | |
| 73630 | 13 | 13 | $227.93 | |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | 14 | 13 | $217.62 |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | 14 | 13 | $217.62 |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | 141 | 125 | $169.80 |
| 85730 | 75 | 68 | $165.04 | |
| 87077 | 47 | 37 | $155.68 | |
| 80076 | 30 | 29 | $146.01 | |
| 87186 | 13 | 12 | $70.98 | |
| J1170 | Injection, hydromorphone, up to 4 mg | 63 | 54 | $63.01 |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | 126 | 110 | $62.26 |
| 85027 | 14 | 14 | $53.57 | |
| J2765 | Injection, metoclopramide hcl, up to 10 mg | 17 | 14 | $13.00 |
| J2001 | Injection, lidocaine hcl for intravenous infusion, 10 mg | 13 | 13 | $0.62 |
| 0353U | 13 | 13 | $0.00 |